UnitedHealth Group (NYSE:UNH) Trading Up 9.3% on Analyst Upgrade

Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded up 9.3% during trading on Tuesday after Sanford C. Bernstein raised their price target on the stock from $405.00 to $411.00. Sanford C. Bernstein currently has an outperform rating on the stock. UnitedHealth Group traded as high as $312.43 and last traded at $307.55. 21,966,661 shares were traded during trading, an increase of 123% from the average session volume of 9,840,573 shares. The stock had previously closed at $281.36.

Other equities analysts have also issued research reports about the company. Truist Financial cut their price target on UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, February 2nd. UBS Group cut their price target on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. Oppenheimer cut their price target on UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating on the stock in a research note on Wednesday, January 28th. Evercore raised UnitedHealth Group to a “strong-buy” rating in a research note on Tuesday, January 6th. Finally, Jefferies Financial Group cut their price target on UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $363.42.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: CMS finalized a materially larger‑than‑expected 2027 Medicare Advantage payment increase (net +2.48%), which adds >$13B to the MA program and directly supports UnitedHealth’s Medicare book and margins. Trump administration finalizes better-than-feared Medicare Advantage payment rate in boost to health insurers (CNBC)
• Positive Sentiment: Market reaction: UNH led a managed‑care relief rally after the CMS news, with coverage noting the move erased much of the regulatory risk that had pressured the stock. UnitedHealth Rockets 11%… (247WallSt)
• Positive Sentiment: Analysts moved quickly: Bank of America and Sanford C. Bernstein among firms raising price targets and ratings, signaling investor confidence that the MA lift supports earnings and valuation recovery. UnitedHealth Price Target Raised to $337 by BofA (247WallSt) Sanford C. Bernstein raises UNH target (TickerReport)
• Positive Sentiment: Several deep‑dive pieces argue the MA rate boost materially improves UNH’s margin outlook and could accelerate a repricing if cost‑cutting and Optum initiatives continue to reduce medical‑cost run‑rate. UnitedHealth: The CMS Boost Changes Everything Now (Seeking Alpha) Quantifying The Impact Of The New CMS Payment Increase (Seeking Alpha)
• Neutral Sentiment: Some headlines attribute part of the policy shift to new CMS leadership (mention of Dr. Oz) — a possible governance/regulatory angle to monitor but not an immediate earnings driver. Why UnitedHealth Group Rallied Today (Motley Fool)
• Neutral Sentiment: Upcoming catalyst: UNH reports Q1 results on April 21 — the print and management commentary will be the next major test of whether the MA tailwind offsets lingering cost pressure. Is April 21 When UnitedHealth Group Finally Sheds Its Problem Past? (247WallSt)
• Negative Sentiment: Despite the MA boost, analysts and coverage warn persistent elevated medical costs and prior weak guidance remain risks — earnings recovery depends on sustaining margin improvement and execution from Optum cost initiatives. UnitedHealth Jumps on CMS’ MA Rate Boost: How to Position Now (Zacks)

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the company. Sarver Vrooman Wealth Advisors bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $25,000. Beacon Financial Strategies CORP bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $26,000. Anfield Capital Management LLC grew its stake in UnitedHealth Group by 220.0% in the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 55 shares in the last quarter. Joseph Group Capital Management bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $27,000. Finally, Nalls Sherbakoff Group LLC bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $27,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

The stock has a market capitalization of $279.16 billion, a P/E ratio of 23.32, a P/E/G ratio of 1.28 and a beta of 0.40. The stock has a 50 day simple moving average of $281.61 and a two-hundred day simple moving average of $319.24. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.72.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The company had revenue of $113.73 billion during the quarter, compared to the consensus estimate of $113.38 billion. During the same period in the previous year, the company posted $6.81 EPS. The firm’s revenue for the quarter was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date was Monday, March 9th. UnitedHealth Group’s payout ratio is currently 67.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.